Loading patent…
AssigneeDermal Research Laboratories, Inc.
InventorsHarold G. Brown, Karen K. Brown, Carol A. Cooper
Estimating the term…
The invention relates to a method of preventing and treating diseases and conditions associated with allergies, autoimmunity, the adhesion cascade, the metastatic cascade or the coronary cascade comprising administering (i) at least one complex carbohydrate as the sole active ingredient, or (ii) at least one pharmaceutical composition which comprises as an active ingredient a pharmacologically effective amount of at least one low purity or cosmetic grade complex carbohydrate selected from the group consisting of oligosaccharides, sialylated oligosaccharides, polysaccharides and glycosaminoglycans, and an effective amount of at least one transdermal or transmucosal carrier in an amount effective to deliver the complex carbohydrate into the blood stream.
A method of treating at least one inflammation-based disease or condition selected from the group consisting of asthma, anaphylaxis, allergy and emphasema, comprising administering hyaluronic acid or a salt thereof to a patient in need thereof, wherein the hyaluronic acid or salt thereof comprises at least one fraction having a molecular weight of greater than 1,000,000 daltons and wherein hyaluronic acid or salt thereof is administered orally or mucosally.
Dependencies are inferred from the claim text.